XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS        
Net sales $ 78,048 $ 71,269 $ 232,346 $ 211,635
Cost of sales 18,510 16,861 56,684 51,757
Gross profit 59,538 54,408 175,662 159,878
Operating expenses:        
Selling, general and administrative 54,247 47,149 161,034 140,998
Research and development 33,301 28,870 101,706 87,459
Acquired in-process research and development     3,000 10,000
Litigation-related settlement       (30,000)
Total operating expenses 87,548 76,019 265,740 208,457
Loss from operations (28,010) (21,611) (90,078) (48,579)
Non-operating expense:        
Interest income 2,710 744 6,252 1,415
Interest expense (3,398) (3,481) (10,205) (10,311)
Other expense, net (1,709) (2,981) (2,978) (9,792)
Total non-operating expense (2,397) (5,718) (6,931) (18,688)
Loss before taxes (30,407) (27,329) (97,009) (67,267)
Income tax provision 37 247 873 468
Net loss $ (30,444) $ (27,576) $ (97,882) $ (67,735)
Basic net loss per share (in dollar per share) $ (0.63) $ (0.58) $ (2.03) $ (1.43)
Diluted net loss per share (in dollar per share) $ (0.63) $ (0.58) $ (2.03) $ (1.43)
Weighted average shares used to compute basic net loss per share 48,675 47,614 48,284 47,346
Weighted average shares used to compute diluted net loss per share 48,675 47,614 48,284 47,346